ResMed, a leader in sleep apnea solutions, recently opened a 270,000 square foot Advanced Manufacturing Centre in Tuas, Singapore. This state-of-the-art facility will double the company's footprint in Asia and support its manufacturing of connected devices. It also has the capacity to scale production for its PAP devices and mask systems.
ResMed's new facility will house over two hundred and thirty jobs and will serve as a major hub for the firm's manufacturing operations in the Asia-Pacific region. The facility will also play a key role in ResMed's overall growth and corporate strategy. In fact, the firm's newest product, the AirSense 11, will be produced at the facility.
One of the most innovative features of the AirSense 11 is the company's cellular technology, which enables users to remotely access their therapy information from their smartphone. The device also boasts a snazzy touchscreen that allows patients to view and monitor their own treatment.
The AirSense device also possesses one of the most elegant CPAPs on the market, as well as a number of other high-tech features. For example, the device's AutoSet function is designed to provide a personalized therapy experience to patients. Another feature of the device is the AirView system, which is a secure, cloud-based system that provides an augmented reality experience.
The AirSense device also possesses other noteworthy features, including the fact that it is the only CPAP on the market that is certified to perform continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) therapies. Other cool features include a clear humidifier chamber, heated tubing, and a filter flap.
Contact the distributor of ResMed in Singapore for more product information.